UiPath Shares Gain 22% as Market Considers Company’s Cash Position Amidst Lagging ARR Increases
29 July 2026
2 mins read

UiPath Shares Gain 22% as Market Considers Company’s Cash Position Amidst Lagging ARR Increases

NEW YORK, July 29, 2026, 1:00 p.m. EDT

UiPath Inc advanced 2.5% to $12.50 during midday trading on Wednesday, extending its four-day recovery to 22.5%. Regular trading hours continued on the New York exchange.

The development occurred in the absence of any recent company statement or SEC filing. The latest updates from UiPath’s official channels were posted on July 15 and July 14. As a result, investors are left to assess valuation ahead of the company’s upcoming growth challenge.

Stock chart for NYSE:PATH
SecurityWednesday changeChange since July 23 close
UiPath +2.5%+22.5%
Appian +4.6%+30.3%
Pegasystems +3.5%+17.5%
iShares Expanded Tech-Software Sector ETF (NYSEARCA:IGV)+0.6%+6.0%

Live prices were captured just before 1 p.m. EDT. Returns are based on closing prices from July 23.

UiPath’s rebound was smaller than Appian’s but exceeded that of Pegasystems, outperforming the main software fund by roughly 16 percentage points. The trend suggests a focused recovery in automation stocks.

The valuation perspective shifts considering the balance sheet. UiPath reported $1.42 billion in cash and marketable securities as of April 30, representing roughly 21% of its present market capitalization.

An initial estimate adjusted for cash places the valuation at approximately $5.18 billion, which equates to around 2.9 times the midpoint of projected revenue guidance for fiscal 2027.

The valuation continues to be challenged by growth expectations. The company’s forecast for the full year suggests around 10.4% revenue expansion. Revenue for the first quarter rose by 17%.

The adjusted operating-income outlook of $430 million suggests a margin of 24.2%. This figure is roughly 1.2 percentage points higher than in fiscal 2026. Most gains in valuation come from stronger margins rather than increased sales.

Annual recurring revenue, or ARR, is a more precise metric. The second-quarter outlook suggests net new ARR between $28 million and $33 million, nearly matching the $31 million reported in the same quarter last year.

The projected increase would decrease by 33% to 43% compared to the opening quarter. UiPath reported a $49 million gain for that interval.

Chief Executive Daniel Dines stated in May that agentic products were “moving from pilot to production.” Annualized recurring revenue for the first quarter increased by 12% to $1.901 billion. Dollar-based net retention stood at 109%. SEC

Profitability provides investors with additional flexibility. UiPath reported operating income of $28 million under generally accepted accounting principles. Operating cash flow totaled $132 million. Adjusted free cash flow amounted to $130 million.

Share repurchases offer an additional method to boost per-share metrics. UiPath allocated $243.8 million to buybacks in the quarter, amounting to 1.85 times its operating cash flow.

The company acquired 20.4 million shares at a mean price of $11.47. On Wednesday, the shares were trading roughly 9% above that level.

The diluted number of shares dropped 3.8% compared to the same period last year. However, cash and securities decreased to $1.42 billion in April, down from $1.69 billion in January. Acquisition expenditures for the quarter amounted to $149.4 million.

The upcoming report needs to demonstrate that agentic deployments are driving an increase in new ARR. If this is not shown, the recovery will depend more on cash, margins, and share repurchases. There is still no evidence of accelerating demand.

Risks: UiPath notes that ARR and retention levels may vary and are not reliable indicators of future performance. Ongoing share repurchases funded with cash could further diminish its balance-sheet buffer.

TS2 TECH • EXTENDED COVERAGE

Further analysis

What is UiPath’s current stock price, and what factors are influencing its movement?

UiPath was last seen at about $12.48 at 12:41 p.m. ET, gaining around 2.4%. The stock has moved between $12.07 and $12.65 so far, with 25.9 million shares changing hands. No press release had been posted to UiPath’s investor-relations page for July 29. The lack of fresh news points to trading activity as the main driver, not earnings. PATH stayed approximately 37% under its 52-week peak of $19.84. UiPath, Inc.

How robust were UiPath’s most recent quarterly earnings?

Revenue for the fiscal first quarter climbed to $418.4 million, up 17% compared to a year earlier. Annualized recurring revenue (ARR) rose 12% to $1.901 billion, and net-new ARR totaled $49 million. GAAP operating income reached $28.0 million, shifting from a $16.4 million loss. Operating cash flow increased 11% to $131.9 million. The quarter showed solid performance. UiPath, Inc.

Does the annual forecast indicate an acceleration in growth?

UiPath projects revenue for fiscal 2027 between $1.776 billion and $1.781 billion, suggesting about 10.4% growth over fiscal 2026 at the midpoint. The company’s ARR forecast stands between $2.058 billion and $2.063 billion, indicating growth of approximately 11.2%. Non-GAAP operating income is expected to be $430 million, or a margin near 24%. Management maintains that full-year growth will remain slower compared to the first quarter’s performance. UiPath, Inc.

How does the second-quarter outlook affect expectations for the upcoming earnings release?

UiPath projects Q2 revenue between $395 million and $400 million, up from $362 million in the prior year. The range’s midpoint signals a year-over-year growth rate of about 9.8%. Guidance for Annualized Recurring Revenue (ARR) is between $1.929 billion and $1.934 billion, indicating close to 12.1% growth. Expected non-GAAP operating income stands at around $75 million. Revenue exceeding $400 million would bolster the case for a reacceleration. UiPath, Inc.

Is there progress in customer retention and enterprise adoption?

Dollar-based net retention climbed to 109%, compared with 108% a year ago, and up from 107% at the end of the previous fiscal year in January. The number of customers with more than $100,000 in ARR increased by 11% to 2,624, while those with more than $1 million in ARR rose 18% to 374. The revenue contribution from customers above $1 million in ARR rose to 52% from 47%. UiPath, Inc.

Has agentic AI begun to generate tangible commercial momentum?

Management reports that agentic products are advancing from pilot phases to active deployment. UiPath recently bought WorkFusion for about $190 million, which includes potential earnouts. WorkFusion provides AI-powered agents focused on financial-crime compliance in the banking sector. UiPath does not break out revenue or ARR specific to agentic-AI. The financial impact has not been specified. UiPath, Inc.

To what extent is UiPath’s profitability progress genuine?

GAAP operating margin rose to 6.7%, with non-GAAP margin coming in around 22%. The company reported GAAP net income of $22.5 million, compared with a prior loss of $22.6 million. Stock-based compensation declined by 30% to $53.3 million, but continued to account for nearly 13% of revenue. Adjusted free cash flow was $130 million; however, a single quarter does not make a trend. UiPath, Inc.

Do the balance sheet and share repurchase offer protection to shareholders?

As of April 30, UiPath reported cash and marketable securities of about $1.42 billion. The company bought back 20.4 million shares at an average price of $11.47. At the quarter’s end, $436.9 million remained under its buyback authorization. UiPath also acquired an additional 2.4 million shares at $9.63 apiece through May 15. Cash declined by roughly $273 million, driven by repurchases and the WorkFusion acquisition. UiPath, Inc.

How do Wall Street analysts currently view PATH stock?

FactSet lists a mean target of $13.47 and a consensus Hold recommendation. Another current summary shows an average target price of $13.25. These estimates suggest a potential upside of 6% to 8% from $12.48. UBS recently lowered its target to $12 from $13 but kept its Neutral stance. Coverage varies by provider, so no single consensus is exact. Moomoo

What is a credible twelve-month price target for UiPath shares?

UiPath traded at $12.48, giving it a market capitalization of approximately $6.59 billion. After subtracting its latest reported cash balance, the value of operating assets stands at about $5.18 billion. This represents nearly 2.9 times projected fiscal 2027 revenue. My base case for the next twelve months is $13.50, based on 3.2 times expected forward sales. The downside scenario is $9.50, while the upside scenario is $18.00. The valuation range depends on retention metrics, Q2 performance, and observed progress in AI monetization. These scenarios represent valuations, not assured outcomes. UiPath, Inc.

Iwona Majkowska is a financial markets journalist at TS2.tech, specializing in stocks, artificial intelligence and technology. A graduate of the Warsaw School of Economics, she previously worked in equity research and financial analysis before focusing on market reporting. Her daily coverage helps investors follow major developments across U.S. and global markets. Follow Iwona Majkowska on Google News.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 BUY IN STAGES

AerCap

NYSE: AER 95 / 100
#2 BUY ON WEAKNESS

Xylem

NYSE: XYL 93 / 100
#3 ACCUMULATE

General Dynamics

NYSE: GD 91 / 100
#4 BUY WITH LIMITS

Visa

NYSE: V 88 / 100
#5 TACTICAL BUY

IDEX

NYSE: IEX 85 / 100
View full portfolio
Editorial model selection. Not personalised advice.
IREN Limited (NASDAQ:IREN) falls as $4 billion-plus AI ramp-up puts delivery to the test
Previous Story

IREN Limited (NASDAQ:IREN) falls as $4 billion-plus AI ramp-up puts delivery to the test

Transocean Ltd. (NYSE:RIG) stock holds near $5.34 as merger spread stays tight
Next Story

Transocean Shares Decline Even as Oil Prices Climb; Valaris Deal Gap Tightens